Sweden Cancels Agreement With Elsevier Over Open Access

A consortium of institutions will not renew its contract with the publisher that ends in June, following the lead of organizations in other countries.

Written byAshley Yeager
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, MARCUS HANSSONA collection of Swedish universities and research institutions will not renew its current contract with Elsevier that expires at the end of June, Times Higher Education reports today (May 16). The move comes not long after academic institutions in other countries have let publishers’ subscriptions lapse when fee negotiations come to an impasse.

“The current system for scholarly communication must change, and our only option is to cancel deals when they don’t meet our demands for a sustainable transition to open access,” Astrid Söderbergh Widding, president of Stockholm University and chair of the consortium, tells OpenAccess.se, a blog published by the National Library of Sweden.

According to the blog, the Bibsam Consortium, representing 85 higher education and research institutions in the country, had requested that Elsevier allow researchers at the institutions to publish their work in open access formats and receive reading access to all of the publisher’s journal articles. The consortium also wanted the publisher to commit to a pricing structure that would encourage the move to open access.

In 2017, the consortium’s members spent €12 million ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other positions. She holds a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT. Ashley edits the Scientist to Watch and Profile sections of the magazine and writes news, features, and other stories for both online and print.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies